High-quality products
Reliable performance
Narlaprevir (codenamed SCH 900518), is an inhibitor of NS3/4A serine protease, intended for the treatment of chronic hepatitis C caused by genotype 1 virus in combination with other antiviral drugs. Narlaprevir is the first Russian tableted medication for the treatment of chronic hepatitis C.
High-quality products
Reliable performance
Wide range of applications
For various laboratory needs
Expert support
Professional service team
Fast delivery
Global shipping